Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells

Nandini Ghosh-Choudhury, Goutam Ghosh-Choudhury, Anthony Celeste, Paramita M Ghosh, Marissa Moyer, Sherry L. Abboud, Jeffrey Kreisberg

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

The biologic effects and mechanisms by which bone morphogenetic proteins (BMPs) function in breast cancer cells are not well defined. A member of this family of growth and differentiation factors, BMP-2, inhibited both basal and estradiol-induced growth of MCF-7 breast tumor cells in culture. Flow cytometric analysis showed that in the presence of BMP-2, 62% and 45% of estradiol-stimulated MCF-7 cells progressed to S-phase at 24 h and 48 h, respectively. Estradiol mediates growth of human breast cancer cells by stimulating cyclins and cyclin-dependent kinases (CDKs). BMP-2 significantly increased the level of the cyclin kinase inhibitor, p21, which in turn associated with and inactivated cyclin D1. BMP-2 inhibited estradiol-induced cyclin D1-associated kinase activity. Also estradiol-induced CDK2 activity was inhibited by BMP-2. This inhibition of CDK activity resulted in hypophosphorylation of retinoblastoma protein thus keeping it in its active form. These data provide the first evidence by which BMP-2 inhibits estradiol-induced proliferation of human breast cancer cells. (C) 2000 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)186-196
Number of pages11
JournalBiochimica et Biophysica Acta - Molecular Cell Research
Volume1497
Issue number2
DOIs
StatePublished - Jul 21 2000
Externally publishedYes

Fingerprint

Cyclin-Dependent Kinase Inhibitor p21
Bone Morphogenetic Protein 2
Retinoblastoma Protein
Estradiol
Breast Neoplasms
Cyclin-Dependent Kinases
Cyclin D1
Growth Differentiation Factors
Bone Morphogenetic Proteins
Cyclins
MCF-7 Cells
Growth
S Phase
Phosphotransferases
Cell Culture Techniques

Keywords

  • BMP-2
  • Breast cancer cell
  • p21
  • pRb

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Biophysics

Cite this

Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells. / Ghosh-Choudhury, Nandini; Ghosh-Choudhury, Goutam; Celeste, Anthony; Ghosh, Paramita M; Moyer, Marissa; Abboud, Sherry L.; Kreisberg, Jeffrey.

In: Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1497, No. 2, 21.07.2000, p. 186-196.

Research output: Contribution to journalArticle

Ghosh-Choudhury, Nandini ; Ghosh-Choudhury, Goutam ; Celeste, Anthony ; Ghosh, Paramita M ; Moyer, Marissa ; Abboud, Sherry L. ; Kreisberg, Jeffrey. / Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells. In: Biochimica et Biophysica Acta - Molecular Cell Research. 2000 ; Vol. 1497, No. 2. pp. 186-196.
@article{de0d4e7035f34e2489c711a704a4d7a0,
title = "Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells",
abstract = "The biologic effects and mechanisms by which bone morphogenetic proteins (BMPs) function in breast cancer cells are not well defined. A member of this family of growth and differentiation factors, BMP-2, inhibited both basal and estradiol-induced growth of MCF-7 breast tumor cells in culture. Flow cytometric analysis showed that in the presence of BMP-2, 62{\%} and 45{\%} of estradiol-stimulated MCF-7 cells progressed to S-phase at 24 h and 48 h, respectively. Estradiol mediates growth of human breast cancer cells by stimulating cyclins and cyclin-dependent kinases (CDKs). BMP-2 significantly increased the level of the cyclin kinase inhibitor, p21, which in turn associated with and inactivated cyclin D1. BMP-2 inhibited estradiol-induced cyclin D1-associated kinase activity. Also estradiol-induced CDK2 activity was inhibited by BMP-2. This inhibition of CDK activity resulted in hypophosphorylation of retinoblastoma protein thus keeping it in its active form. These data provide the first evidence by which BMP-2 inhibits estradiol-induced proliferation of human breast cancer cells. (C) 2000 Elsevier Science B.V.",
keywords = "BMP-2, Breast cancer cell, p21, pRb",
author = "Nandini Ghosh-Choudhury and Goutam Ghosh-Choudhury and Anthony Celeste and Ghosh, {Paramita M} and Marissa Moyer and Abboud, {Sherry L.} and Jeffrey Kreisberg",
year = "2000",
month = "7",
day = "21",
doi = "10.1016/S0167-4889(00)00060-4",
language = "English (US)",
volume = "1497",
pages = "186--196",
journal = "Biochimica et Biophysica Acta - Molecular Cell Research",
issn = "0167-4889",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells

AU - Ghosh-Choudhury, Nandini

AU - Ghosh-Choudhury, Goutam

AU - Celeste, Anthony

AU - Ghosh, Paramita M

AU - Moyer, Marissa

AU - Abboud, Sherry L.

AU - Kreisberg, Jeffrey

PY - 2000/7/21

Y1 - 2000/7/21

N2 - The biologic effects and mechanisms by which bone morphogenetic proteins (BMPs) function in breast cancer cells are not well defined. A member of this family of growth and differentiation factors, BMP-2, inhibited both basal and estradiol-induced growth of MCF-7 breast tumor cells in culture. Flow cytometric analysis showed that in the presence of BMP-2, 62% and 45% of estradiol-stimulated MCF-7 cells progressed to S-phase at 24 h and 48 h, respectively. Estradiol mediates growth of human breast cancer cells by stimulating cyclins and cyclin-dependent kinases (CDKs). BMP-2 significantly increased the level of the cyclin kinase inhibitor, p21, which in turn associated with and inactivated cyclin D1. BMP-2 inhibited estradiol-induced cyclin D1-associated kinase activity. Also estradiol-induced CDK2 activity was inhibited by BMP-2. This inhibition of CDK activity resulted in hypophosphorylation of retinoblastoma protein thus keeping it in its active form. These data provide the first evidence by which BMP-2 inhibits estradiol-induced proliferation of human breast cancer cells. (C) 2000 Elsevier Science B.V.

AB - The biologic effects and mechanisms by which bone morphogenetic proteins (BMPs) function in breast cancer cells are not well defined. A member of this family of growth and differentiation factors, BMP-2, inhibited both basal and estradiol-induced growth of MCF-7 breast tumor cells in culture. Flow cytometric analysis showed that in the presence of BMP-2, 62% and 45% of estradiol-stimulated MCF-7 cells progressed to S-phase at 24 h and 48 h, respectively. Estradiol mediates growth of human breast cancer cells by stimulating cyclins and cyclin-dependent kinases (CDKs). BMP-2 significantly increased the level of the cyclin kinase inhibitor, p21, which in turn associated with and inactivated cyclin D1. BMP-2 inhibited estradiol-induced cyclin D1-associated kinase activity. Also estradiol-induced CDK2 activity was inhibited by BMP-2. This inhibition of CDK activity resulted in hypophosphorylation of retinoblastoma protein thus keeping it in its active form. These data provide the first evidence by which BMP-2 inhibits estradiol-induced proliferation of human breast cancer cells. (C) 2000 Elsevier Science B.V.

KW - BMP-2

KW - Breast cancer cell

KW - p21

KW - pRb

UR - http://www.scopus.com/inward/record.url?scp=0034698099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034698099&partnerID=8YFLogxK

U2 - 10.1016/S0167-4889(00)00060-4

DO - 10.1016/S0167-4889(00)00060-4

M3 - Article

VL - 1497

SP - 186

EP - 196

JO - Biochimica et Biophysica Acta - Molecular Cell Research

JF - Biochimica et Biophysica Acta - Molecular Cell Research

SN - 0167-4889

IS - 2

ER -